AGS Associates’ Post

Heartbeat of Innovation: 4 Trends Shaping Cardiac Medtech in 2024 🫀 Exciting developments in cardiac medtech are continuing to advance. Pulsed field ablation (PFA) is emerging as a game-changer in atrial fibrillation treatment, with Medtronic, Boston Scientific, Johnson & Johnson MedTech, and Abbott locked in a "two-horse race" for this safer, more precise alternative to traditional ablation methods. The market is expected to double by 2028, with PFA taking over 60% of procedures! Additionally, Boston Sci’s Watchman device dominates the left atrial appendage closure market, projected to quadruple by 2030. However, Medtronic acquiring the Penditure system and J&J developing a LAA elimination approach, heats up the competition. Edwards Lifesciences is also expanding its reach, with a focus on mitral and tricuspid valve therapies. Pascal repair system and Evoque tricuspid valve aim to challenge competitors and treat more patients. These are just a few of the exciting trends shaping medtech, where else are you seeing significant advancements? #MedTech #Cardiovascular #AFib #LAA #Hypertension #TAVR #Innovation #healthcare Read more: https://lnkd.in/dB-8q-EE

𝗜𝗺𝗽𝗹𝗮𝗻𝘁𝗮𝗯𝗹𝗲 𝗖𝗮𝗿𝗱𝗶𝗮𝗰 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟮. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The report offers an overview of the Implantable Cardiac Monitors industry chain's development, examining the market status of Hospitals (Cardiac Arrhythmias, Atrial Fibrillation), Cardiac Centers & Clinics (Cardiac Arrhythmias, Atrial Fibrillation), and key enterprises in both developed and developing markets. It analyzes cutting-edge technology, patents, emerging applications, and market trends within the Implantable Cardiac Monitors sector. Regionally, North America and Europe show stable growth propelled by government initiatives and rising consumer awareness, while Asia-Pacific, particularly China, leads the global market due to robust domestic demand, supportive policies, and a strong manufacturing foundation. The report provides a comprehensive understanding of the Implantable Cardiac Monitors market, offering insights into industry dynamics, trends, challenges, and opportunities for stakeholders. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗜𝗺𝗽𝗹𝗮𝗻𝘁𝗮𝗯𝗹𝗲 𝗖𝗮𝗿𝗱𝗶𝗮𝗰 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝘀 𝗠𝗮𝗿𝗸𝗲𝘁.𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dSE9_wxB *𝗕𝘆 𝗧𝘆𝗽𝗲: Cardiac Arrhythmias,  Atrial Fibrillation,  Epilepsy & Unexplained Falls *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Hospitals,  Cardiac Center & Clinics,  Ambulatory Surgical Centers (ASCs) *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Abbott Laboratories,  BIOTRONIK,  Boston Scientific,  Edwards Lifesciences,  GE HealthCare,  Koninklijke Philips (Philips Healthcare),  Livanova Plc (Sorin),  Medtronic Plc,  Nihon Kohden Co,  Phoenix Heart PLLC #implantablecardiacmonitors #ICM #cardiactechnology #hearthealth #cardiacmonitoring #medicaldevices #healthcaretechnology #cardiaccare #heartmonitor #arrhythmia #cardiovascularhealth #heartdisease #cardiology #monitoringdevices #healthtech #wearabletech #medicalinnovation #heartmonitoring #patientcare #healthmonitoring #cardiacpatients

Canary Completes First-in-Human Trial of Cardiac Auscultation Monitoring Sensor Canary Medical Inc. focused on the development and commercialization of its patented implantable sensor technology and complementary data and analytics ecosystem, today announced the completion of the first-in-human limited feasibility trial of their Cardiac Auscultation (Acoustic) monitoring sensor device. The device is being developed as a first-in-class implantable sensor to provide daily adjunctive objective cardiac parameter measurements enabling patients and clinicians to better manage their congestive heart failure symptoms with current medication management tools. This trial, conducted in Paraguay, represents the first successful human implantation of a cardiac auscultation sensor device. The U.S. heart failure market is projected to be $70B annually by 2030. One in five people will develop heart failure in their lifetime with half of patients dying within five years of their diagnosis. #heartfailure #heartdisease https://lnkd.in/eG8v8hMe

According to the report, the #cardiac #pacemakers market size was valued at USD 4,446.2 million in 2023, at a CAGR of 5.6% during the forecast period 2024-30. 𝐁𝐲 𝐓𝐲𝐩𝐞: The market is segmented into #implantable #pacemaker, #external #pacemaker 𝐁𝐲 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲: The market is segmented into #single #chambered, #biventricular, #dual chambered 𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫: The market is segmented into #ambulatory #surgical #centers, #hospitals, #clinics Abbott, Medtronic, OSYPKA MEDICAL GmbH, BIOTRONIK, Boston Scientific, Medicines for Europe, Lepu Medical Technology (Beijing) Co., Ltd., Shree Pacetronix Ltd #marketanalysis #marketgrowth #marketdata #marketsize #marketshare #markettrends #marketreport #marketoutlook #marketoverview #drivers #marketresearchreport #marketsegmentation #marketsummary #restraints #researchanddevelopment #researchmethods #researchreport #marketdemand

A Comprehensive Analysis of the Mechanical Thrombectomy Devices Market The mechanical thrombectomy devices market is undergoing a comprehensive analysis to understand its dynamics and potential. These devices play a crucial role in the treatment of acute ischemic stroke by removing blood clots from blocked blood vessels. The market is expected to witness significant growth due to factors such as the increasing prevalence of stroke, advancements in technology, and rising awareness about the benefits of mechanical thrombectomy. Additionally, the growing geriatric population and the rising demand for minimally invasive procedures are driving the adoption of these devices. However, challenges such as high costs, limited access to healthcare facilities, and stringent regulatory requirements may impact market growth. Top Players: Stryker, Boston Scientific, Medtronic, Terumo Medical Corporation, Penumbra, Inc., Spectranetics, Teleflex, Argon Medical Devices, Inc. #thrombectomy #mechanicalthrombectomy #medicaldevices #theinsightpartners #marketresearch For More Insights: https://lnkd.in/dgrfeTn4

𝐂𝐨𝐧𝐠𝐞𝐬𝐭𝐢𝐯𝐞 𝐇𝐞𝐚𝐫𝐭 𝐅𝐚𝐢𝐥𝐮𝐫𝐞 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞 & 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟑𝟒 ▶𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/dsqmx_e9 The Global Congestive Heart Failure Treatment Devices market, valued at USD 5.5 billion in 2021, is anticipated to grow from USD 6.4 billion in 2023 to USD 13 billion by 2032, exhibiting a CAGR of 8% during the forecast period. These devices, known as mechanical circulatory support systems, include implantable cardioverter defibrillators, cardiac resynchronization therapy devices, pacemakers, and various ventricular assist devices like left (LVADs) and right (RVADs) options. LVADs and RVADs serve as permanent solutions for patients with limited cardiac muscle improvement prospects. Implantable cardiac defibrillators monitor heart rhythms and administer shocks during abnormal rhythms. The market's growth is driven by increasing cardiovascular disease prevalence, heightened risk of organ failure, and substantial investments by industry leaders in device development, particularly ventricular assist devices, meeting rising demand stemming from growing heart failure cases.   𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: ▶𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞: Pacemakers, Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillators, Ventricular Assist Devices. ▶𝐄𝐧𝐝 𝐔𝐬𝐞𝐫: Hospitals & Clinic, Specialized Cardiovascular Disease Treatment Centres, Ambulatory Surgery Centres. ▶𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧: North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA). 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐜𝐨𝐯𝐞𝐫𝐞𝐝: Boston Scientific, Abbott, Johnson Lifts Middle East Services LLC, Mayo Family Foundation, Medtronic, BIOTRONIK, LivaNova, Berlin Heart GmbH, Abiomed, ReliantHeart Inc., St. Jude Medical, Teleflex, Edwards Lifesciences, Jarvik Heart, Inc., MicroPort Scientific India Pvt. Ltd.           #HeartFailureTreatment #CHFDevices #CardiacHealth #HeartHealth #MedicalDevices #DigitalHealth #HeartFailureAwareness #HeartCare #HealthTech #InnovationInCardiology #CardiovascularHealth #CHFTreatment #HeartDisease #MedTech #HeartFailurePrevention #HealthcareInnovation #PatientCare #HeartFailureResearch #MedicalInnovation #GlobalHealthcare

Minute in Medtech:  A perspective from an aspiring Biomedical Engineer, Competitive Cyclist, CHD Warrior, and typical(?) Teen… In the previous edition of #minuteinmedtech, I discussed Boston Scientific’s BodyGuardian MINI PLUS, a modernized Holter monitoring device. I have first-hand experience with this device and used it to my advantage in the previous publication. In today’s edition, I will cover another cardiovascular device made by Boston Scientific: The #FARAPULSE Pulsed Field Ablation System. The FARAPULSE Pulsed Field Ablation System offers a unique approach to treating atrial fibrillation, commonly known as #AFib. The device uses high electrical signal output to target specific heart cells causing arrhythmia through a catheterization procedure. This approach is different from other methods as it doesn't use thermal heat to destroy cells but instead relies on these electrical signals. The design of the catheter transitions from a rounded basket to a flattened, looping flower shape, allowing precise positioning of the device within the pulmonary vein. The device's design contributes to safer and more favorable procedural outcomes, such as the absence of esophageal injury and pulmonary vein stenosis. This device reminded me of two other devices I have discussed in the past: the #POLARx Cryoablation System, also created by Boston Scientific. This device addresses the issue of Arterial Fibrosis, caused by misfiring electrical signals, resulting in the upper arterial chambers of the heart being uncoordinated with the lower ventricle chamber, leading to rapid heartbeats and overall poor circulation and cardiac output. The POLARx Cryoablation system employs cryo-therapeutic methods on problematic tissues causing electrical issues in the heart. These two devices offer unique approaches to similar issues, one using a temperature-based strategy to eliminate problematic cells and the other utilizing high electrical signals. The variety of approaches for these issues empowers cardiologists to choose the most effective and efficient path for treatment for each patient. Thanks for reading. If you are interested in more of what Boston Scientific is doing, check them out using this link: https://lnkd.in/eYQz4Ksk Follow me at #MinuteInMedtech for more innovative and interesting medical devices. To note, this is my opinion and I am not being compensated for this post.

🔍 2024 is shaping up to be an interesting year for cardiac care with some key trends on the horizon… Medtronic, Boston Scientific, and others are leading the charge with PFA for AFib treatment, signalling a leap forward in precision and patient safety 🤞 The competition is heating up in left atrial appendage closure, with Boston Scientific's Watchman device facing new rivals. Meanwhile, the debate around reimbursement for renal denervation treatments highlights the challenges and opportunities in addressing hypertension. Lastly, heart valve procedures are expanding to reach more patients, reflecting the sector's recovery and growth potential post-COVID. All the info can be found in the article below 👇 #TAVR #AFib #cardiac #cardiology

𝐑𝐢𝐬𝐢𝐧𝐠 𝐃𝐞𝐦𝐚𝐧𝐝 𝐢𝐧 𝐄𝐥𝐞𝐜𝐭𝐫𝐨𝐩𝐡𝐲𝐬𝐢𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐁𝐨𝐨𝐧 𝐟𝐨𝐫 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 The global #electrophysiology_market is expected to see a surge at a CAGR of 10.5% by 2028, driven by factors like: 🔶Increasing prevalence of cardiac arrhythmias 🔶Growing need for minimally invasive procedures 🔶Supportive reimbursement policies 𝐎𝐮𝐫 𝐢𝐧-𝐝𝐞𝐩𝐭𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 𝐨𝐧 𝐭𝐡𝐞 𝐄𝐥𝐞𝐜𝐭𝐫𝐨𝐩𝐡𝐲𝐬𝐢𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐨𝐟𝐟𝐞𝐫𝐬 𝐚 𝐝𝐞𝐞𝐩 𝐝𝐢𝐯𝐞 𝐢𝐧𝐭𝐨: 🔶Market #size and forecast 🔶Segmentation by product and end-user 🔶Growth drivers and #trends 🔶Competitive landscape 𝐆𝐞𝐭 𝐚 𝐂𝐨𝐦𝐩𝐥𝐢𝐦𝐞𝐧𝐭𝐚𝐫𝐲 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (2024-30): https://lnkd.in/g35V6zQF 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Abbott, Medtronic, Boston Scientific, Koninklijke Kentalis, General Electric Company, Siemens Healthineers and Others. #health #healthcare #healthcareindustry #electrophysiology #medicaldevices #marketresearch #marketintelligence #marketresearchreports #marketanalysis #marketgrowth #industryanalysis #industrygrowth #consulting #marknteladvisors